Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-03-20 Option Award | 2025-03-24 5:00 pm | N/A 2035-03-20 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 400,000 | $0 | 3,476,703 (Direct) | View |
| 2025-03-06 Option Award | 2025-03-10 5:00 pm | 2025-03-06 2026-03-06 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 812,500 | $1.12 | 3,889,203 (Indirect) | View |
| 2025-01-03 Option Award | 2025-01-07 4:30 pm | 2025-01-03 2035-01-03 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 152,672,000 | $0 | 5,493,579,500 (Direct) | View |
| 2025-01-03 Option Award | 2025-01-07 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 208,000 | $0.0006 | 5,493,579,500 (Indirect) | View |
| 2024-12-26 Option Award | 2024-12-30 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 3,600,000 | $0.0005 | 5,340,699,500 (Indirect) | View |
| 2024-12-24 Option Award | 2024-12-27 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 7,500,000 | $0.0005 | 5,337,099,500 (Indirect) | View |
| 2024-12-23 Option Award | 2024-12-26 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,400,000 | $0.0005 | 5,329,599,500 (Indirect) | View |
| 2024-12-20 Option Award | 2024-12-26 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,400,000 | $0.0005 | 5,328,199,500 (Indirect) | View |
| 2024-11-30 Option Award | 2024-12-03 5:50 pm | 2024-11-30 2034-11-30 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 162,604,000 | $0 | 5,908,689,500 (Direct) | View |
| 2024-12-02 Option Award | 2024-12-03 5:50 pm | 2024-12-02 2027-12-02 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 419,286,000 | $0.0012 | 5,908,689,500 (Indirect) | View |
| 2024-11-14 Option Award | 2024-11-18 8:02 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,404,622,000 | $0 | 4,907,513,500 (Indirect) | View |
| 2024-10-31 Option Award | 2024-11-01 6:00 pm | 2024-10-31 2034-10-31 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 79,684,000 | $0 | 79,684,000 (Direct) | View |
| 2024-09-30 Option Award | 2024-10-02 6:34 pm | 2024-09-30 2034-09-30 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 175,080,000 | $0 | 175,080,000 (Direct) | View |
| 2024-06-30 Option Award | 2024-07-02 4:30 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 91,396,000 | $0 | 3,502,891,500 (Direct) | View |
| 2024-05-31 Option Award | 2024-06-04 4:45 pm | 2024-05-31 2027-05-31 | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 1,326,258,000 | $0.0009 | 4,737,753,500 (Indirect) | View |
Ownership | 2024-01-02 7:56 pm | N/A N/A | Akari Therapeutics Plc | AKTX | Patel Samir Rashmikant Director | 0 | $0 | 2,612,011,500 (Indirect) | View |
| 2021-11-24 Option Award(A) | 2021-11-30 6:31 pm | N/A 2031-10-18 | CytoDyn Inc. | CYDY | Patel Samir Rashmikant Director | 349,829 | $0 | 349,829 (Direct) | View |
| 2021-11-24 Option Award | 2021-11-29 6:30 pm | N/A 2031-10-18 | CytoDyn Inc. | CYDY | Patel Samir Rashmikant Director | 331,079 | $0 | 331,079 (Direct) | View |
| 2021-10-18 Option Award | 2021-10-20 4:10 pm | N/A 2031-10-18 | CytoDyn Inc. | CYDY | Patel Samir Rashmikant Director | 225,000 | $0 | 225,000 (Direct) | View |